|
Jul 23
|
Invest $50K in CVS Health and Gilead Sciences to Become a Dividend Millionaire
|
|
Jul 23
|
ViiV Healthcare’s Dovato as effective as Biktarvy in Phase IV HIV trial
|
|
Jul 23
|
Nanotechnology in medicine: Who are the leading public companies?
|
|
Jul 22
|
Gilead Sciences (GILD) Stock Declines While Market Improves: Some Information for Investors
|
|
Jul 22
|
UNAIDS boss calls on Gilead to provide ‘miracle’ drug to developing countries
|
|
Jul 22
|
Gilead and the Elton John AIDS Foundation Announce Additional Five Years of RADIAN Partnership to Help Address the Growing HIV Crisis in Eastern Europe and Central Asia
|
|
Jul 20
|
Gilead Sciences' (NASDAQ:GILD) one-year decline in earnings translates into losses for shareholders
|
|
Jul 18
|
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
|
|
Jul 17
|
Chief Medical Officer Merdad Parsey to Leave Gilead Early 2025
|
|
Jul 17
|
Want $3,000 In Passive Income? Invest $51,000 in These 3 High-Yield Dividend Plays
|
|
Jul 17
|
Gilead set to unveil data from HIV/AIDS trials
|
|
Jan 16
|
Gilead Sciences with Emma's Story: Self-Advocacy in Breast Cancer
|
|
Jan 12
|
Gilead Sciences Inc's Chief Commercial Officer Johanna Mercier Sells 8,242 Shares
|
|
Jan 11
|
Gilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know
|
|
Jan 10
|
JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market
|
|
Jan 10
|
Gilead Pays Tribute to Patient Advocacy Work: Cara’s Story
|